The estimated Net Worth of Walter S Tomenson is at least $94.6 Tysiąc dollars as of 22 May 2015. Mr. Tomenson owns over 10,350 units of Psychemedics stock worth over $94,592 and over the last 21 years he sold PMD stock worth over $0. In addition, he makes $0 as Independent Director at Psychemedics.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Tomenson PMD stock SEC Form 4 insiders trading
Walter has made over 3 trades of the Psychemedics stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 10,350 units of PMD stock worth $149,040 on 22 May 2015.
The largest trade he's ever made was exercising 10,350 units of Psychemedics stock on 22 May 2015 worth over $149,040. On average, Walter trades about 983 units every 38 days since 2004. As of 22 May 2015 he still owns at least 41,579 units of Psychemedics stock.
You can see the complete history of Mr. Tomenson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Walter Tomenson biography
Walter S. Tomenson Jr. serves as Independent Director of the Company. He was a senior advisor to Integro Ltd., having retired in 2011. Mr. Tomenson was Managing Director and Chairman of Client Development of Marsh, Inc. from 1998 until 2004. From 1983 to 1998 he was Chairman of FINPRO, the financial/professional services division of Marsh, Inc. Mr. Tomenson is a Trustee of Trinity College School Fund, Inc. He also serves on the Executive Council of Inner-City Scholarship Fund. He is a board member and Vice-Chairman of the Achievement Centers for Children and Families (Delray Beach, FL). Mr. Tomenson holds an Executive Masters Professional Director Certification, their highest level award, from the American College of Corporate Directors. As a result of these and other professional experiences, Mr. Tomenson possesses particular knowledge and experience in marketing and distribution and human resources that strengthen the Board’s collective qualifications, skills and experience. Mr. Tomenson has been a director of the Company since 1999.
How old is Walter Tomenson?
Walter Tomenson is 73, he's been the Independent Director of Psychemedics since 1999. There are 6 older and 4 younger executives at Psychemedics. The oldest executive at Psychemedics Corp. is Harry Connick, 94, who is the Independent Director.
What's Walter Tomenson's mailing address?
Walter's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 289 GREAT ROAD, SUITE 200, ACTON, MA, 01720.
Insiders trading at Psychemedics
Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen oraz Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.
What does Psychemedics do?
psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics' clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.
What does Psychemedics's logo look like?
Complete history of Mr. Tomenson stock trades at Psychemedics
Psychemedics executives and stock owners
Psychemedics executives and other stock owners filed with the SEC include:
-
Raymond Kubacki,
Chairman of the Board, President, Chief Executive Officer -
Raymond C. Kubacki,
Chairman, CEO & Pres -
Charles Doucot,
Executive Vice President -
Michael Schaffer,
Vice President - Laboratory Operations -
Charles M. Doucot IV,
Exec. VP -
Dr. Michael I. Schaffer Ph.D.,
VP of Laboratory Operations -
A. Clinton Allen,
Independent Director -
Fred Weinert,
Independent Director -
Walter Tomenson,
Independent Director -
Harry Connick,
Independent Director -
Patrick J. Kinney Jr.,
Sec. -
Sarah Ashby,
VP & Gen. Counsel -
Andrew Limbek,
VP of Fin. & Controller -
Annette Baumgartner,
Founder -
Dr. Werner A. Baumgartner Ph.D.,
Founder -
Peter Kamin,
Director -
Neil Lerner,
VP - Finance -
James V. Dyke,
Vice President - Sales -
Michael Weisenhoff,
-
Raymond J Ruddy,
Vice President/Controller -
Jonathan D Compton,
Vice President - Marketing -
William R Thistle,
Sr. VP and Gen. Counsel -
Peter C Monson,
VP, Treas., CFO & Asst. Sec. -
Jennifer Chmieleski,
Vice President, Controller -
Richard T Christoph,
10% owner -
William Dausey,
Vice President of Sales -
Robyn C Davis,
Director -
Andrew Reynolds,
Director -
Shannon Shoemaker,
Chief Revenue Officer -
Darius G Nevin,
Director -
Brian Hullinger,
President & CEO -
Daniella Mehalik,
Vice President - Finance